Report #2838090

Overview

Sex

Male

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Facial nerve inflammation; This serious case was reported by a consumer via call center representative and described the occurrence of neuritis cranial in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, several months after receiving Shingrix, the patient experienced neuritis cranial (Verbatim: Facial nerve inflammation) (serious criteria GSK medically significant). The outcome of the neuritis cranial was unknown. It was unknown if the reporter considered the neuritis cranial to be related to Shingrix. The company considered the neuritis cranial to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 22-APR-2025 Consumer reported that a few months after receiving Shingrix, he experienced facial nerve inflammation.; Sender's Comments: Neuritis cranial is an unlisted event which is considered unrelated to GSK vaccine Shingrix